Physician profile
Gregory Phillips
NPI 1679784607
$4,919.29
in general payments reported to CMS, 2019-2025
37 companies · $737 in 2025
The $737 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $648 · 2021: $819 · 2022: $671 · 2023: $1,079 · 2024: $531 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,346.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $919.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $673.20 | 2019-2025 | |
| Astellas Pharma US INC | $301.52 | 2023-2025 | Veozah, Myrbetriq |
| Currax Pharmaceuticals LLC | $278.27 | 2019-2024 | Contrave |
| Sumitomo Pharma America, INC. | $271.74 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $255.75 | 2022-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $219.53 | 2019-2023 | |
| Avion Pharmaceuticals | $219.48 | 2019-2023 | Balcoltra |
| Lupin INC. | $170.87 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $163.02 | 2023-2025 | |
| Coopersurgical, INC. | $159.51 | 2020-2023 | Summit Doppler, Mara Console |
| Organon LLC | $149.78 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $141.13 | 2019-2025 | Zurzuvae |
| Pfizer INC. | $121.14 | 2019-2024 | |
| Myriad Women'S Health, INC. | $96.57 | 2023 | Myrisk |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.